ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways
Marta Riera, Claudia Martyn, Jordi Pujol-Brugués, Eva Márquez, Eva Rodríguez, Vanesa Palau, María José Soler, Juan Sebastián Salazar Castañeda, Melissa Pilco Teran, Jimena Del Risco, Marta Crespo, Clara Barrios
This study shows that deleting ADAM17 globally protects against diabetes-induced kidney injury by reducing inflammation and fibrosis in a mouse model.
bioRxiv · Feb 8, 2026 · PreprintPathology